Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
189.65
-0.28 (-0.15%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $5.49 billion as of October 29, 2025. Its market cap has increased by 10.34% in one year.
Market Cap
5.49B
Enterprise Value
4.68B
1-Year Change
10.34%
Ranking
Category
Stock Price
$189.65
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $5.49B, an increase of 5,840.52%. That is a compound annual growth rate of 65.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 5.50B | 22.01% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.12B |
| Johnson & Johnson | 456.07B |
| AbbVie | 402.70B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 219.49B |